Example: Heart Attack

Clinical Trials on Purpura, Thrombocytopenic

Total 344 results

NCT02201290

Completed

A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Conditions: Purpura, Thrombocytopenic, Idiopathic
NCT00706342

Completed

Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)

Conditions: Purpura, Thrombocytopenic, Idiopathic
NCT02403440

Unknown status

A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

Conditions: Purpura, Thrombocytopenic, Idiopathic
NCT01098487

Completed

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Conditions: Purpura, Thrombocytopaenic, Idiopathic
NCT00372892

Completed

Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

Conditions: Purpura, Thrombocytopenic, Idiopathic
NCT00424177

Completed

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Conditions: Purpura, Thrombocytopaenic, Idiopathic
NCT02009761

Terminated

Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).

Conditions: Purpura, Thrombocytopenic, Idiopathic
NCT00441090

Completed

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Conditions: Chronic Idiopathic Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Idiopathic
NCT03123497

Recruiting

Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)

Conditions: Idiopathic Thrombocytopenic Purpura
NCT02076399

Completed

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Conditions: Immune Thrombocytopenic Purpura
NCT00540423

Completed

Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Conditions: Chronic Idiopathic Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Idiopathic
NCT00828750

Completed

Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Conditions: Idiopathic Thrombocytopenic Purpura; Purpura, Thrombocytopenic, Idiopathic
NCT03237819

Unknown status

Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care

Conditions: Thrombotic Thrombocytopenic Purpura
NCT01571349

Completed

Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura

Conditions: Idiopathic Thrombocytopenic Purpura
NCT03244410

Unknown status

Lymphocyte Counts in Immune Thrombocytopenic Purpura

Conditions: Thrombocytopenic Purpura
NCT00005570

Completed

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

Conditions: Purpura, Thrombocytopenic, Idiopathic; Immune Thrombocytopenic Purpura
NCT00107913

Unknown status

Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura

Conditions: Autoimmune Thrombocytopenic Purpura
NCT00244257

Terminated

Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Conditions: Idiopathic Thrombocytopenic Purpura
NCT03866577

Recruiting

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Conditions: Immune Thrombocytopenic Purpura (ITP)
NCT04323748

Not yet recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura
NCT04128358

Not yet recruiting

Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?

Conditions: Idiopathic Thrombocytopenic Purpura
NCT04132050

Recruiting

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Conditions: Idiopathic Thrombocytopenic Purpura
NCT00991939

Terminated

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura
NCT00117143

Completed

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Conditions: Thrombocytopenic Purpura
NCT00621894

Completed

Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation

Conditions: Immune Thrombocytopenic Purpura